Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Marwick TH, Amann KU, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Sarnak MJ, Banerjee D, Briguori C, Chang TI, Chen CL, deFilippi CR, Ding X, Ferro CJ, Gill J, Gössl M, Isbel NM, Ishii H, Jardine MJ, Kalra PA, Laufer G, Lentine KL, Lobdell KW, Lok CE, London GM, Małyszko J, Mark PB, Nie Y, Parfrey PS, Pecoits-Filho R, Pilmore H, Qunibi WY, Raggi P, Rattazzi M, Rossignol P, Ruturi J, Sabanayagam C, Shanahan CM, Shroff GR, Shroff R, Webster AC, Weiner DE, Winther S, Wiseman AC, Yip A, Zarbock A, Marwan M (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Kidney International Nature Publishing Group: Open Access Hybrid Model Option A

Book Volume: 96

Pages Range: 836-849

Journal Issue: 4

DOI: 10.1016/j.kint.2019.06.025

Abstract

Chronic kidney disease (CKD) is a major risk factor for valvular heart disease (VHD). Mitral annular and aortic valve calcifications are highly prevalent in CKD patients and commonly lead to valvular stenosis and regurgitation, as well as complications including conduction system abnormalities and endocarditis. VHD, especially mitral regurgitation and aortic stenosis, is associated with significantly reduced survival among CKD patients. Knowledge related to VHD in the general population is not always applicable to CKD patients because the pathophysiology may be different, and CKD patients have a high prevalence of comorbid conditions and elevated risk for periprocedural complications and mortality. This Kidney Disease: Improving Global Outcomes (KDIGO) review of CKD and VHD seeks to improve understanding of the epidemiology, pathophysiology, diagnosis, and treatment of VHD in CKD by summarizing knowledge gaps, areas of controversy, and priorities for research.

Authors with CRIS profile

Kerstin Ute Amann Department of Nephropathology Mohamed Marwan Department of Medicine 2 – Cardiology and Angiology

Involved external institutions

Baker Idi Heart And Diabetes Institute AU Australia (AU) New York University (NYU) US United States (USA) (US) Abbott Northwestern Hospital US United States (USA) (US) Flinders University AU Australia (AU) University of British Columbia CA Canada (CA) Stanford University US United States (USA) (US) University of Glasgow GB United Kingdom (GB) Charité - Universitätsmedizin Berlin DE Germany (DE) Duke University Medical Center US United States (USA) (US) Hennepin County Medical Center US United States (USA) (US) Kidney Disease: Improving Global Outcomes (KDIGO) BE Belgium (BE) University College London (UCL) GB United Kingdom (GB) Baylor College of Medicine US United States (USA) (US) Tufts Medical Center US United States (USA) (US)

How to cite

APA:

Marwick, T.H., Amann, K.U., Bangalore, S., Cavalcante, J.L., Charytan, D.M., Craig, J.C.,... Marwan, M. (2019). Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 96(4), 836-849. https://doi.org/10.1016/j.kint.2019.06.025

MLA:

Marwick, Thomas H., et al. "Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference." Kidney International 96.4 (2019): 836-849.

BibTeX: Download